BioVector® GM04126 Human Untransformed Fibroblast Cell Line / BioVector® GM04126 人类未转化皮肤成纤维细胞株（Wolf-Hirschhorn 综合征染色体缺失模型）

I Product General Information and Cellular Background

• Cell Line Nomenclature: BioVector® GM04126 (Cataloged under the NIGMS Human Genetic Cell Repository at the Coriell Institute for Medical Research).

• Organism Source: Human (Homo sapiens), derived from a 1-year-old male donor.

• Cellular Morphology and Lineage: Untransformed, primary-like skin fibroblast. It grows as an adherent monolayer exhibiting a classic spindle-shaped, elongated fibroblast configuration.

• Genetic Architecture & Cytogenetic Disease Profile (The WHS Landmark Model):

  BioVector® GM04126 is a vital, historically documented cytogenetic model for Wolf-Hirschhorn Syndrome (WHS), a rare neurodevelopmental disorder caused by a contiguous gene deletion on the short arm of chromosome 4.

  • Karyotypic Formula: 46,XY,del(4)(p15.1) [verified across multiple passages].

  • Chromosomal Aberration Mapping: The cells carry a large terminal/interstitial hemizygous deletion mapping to the short arm of chromosome 4, specifically encompassing the monosomic genomic segment (-)4pter ➔ 4p15. This deletion disrupts the critical Wolf-Hirschhorn Syndrome Critical Region (WHCR), making this cell line an invaluable resource for studying human haploinsufficiency.

II Strategic Research Value and Applications

Because BioVector® GM04126 retains its native, non-immortalized disease-specific genomic deletion, it is extensively utilized in developmental genetics and cytogenetic research:

1. Wolf-Hirschhorn Syndrome (WHS) Pathophysiology:

   Used to evaluate downstream functional defects resulting from the loss of key genes located in the 4p16.3 region, such as WHSC1 (NSD2, a histone methyltransferase linked to chromatin remodeling), LETM1 (a mitochondrial calcium/proton antiporter associated with seizures), and MSX1 (linked to craniofacial abnormalities).

2. Induced Pluripotent Stem Cell (iPSC) Reprogramming:

   BioVector® GM04126 serves as a primary donor cell template for generating WHS-patient specific iPSCs through the delivery of Yamanka factors (Oct4, Sox2, Klf4, c-Myc). This allows researchers to establish human neural progenitor cell (NPC) or organoid lineages to investigate the developmental biology of microcephaly, intellectual disability, and midline defects.

3. High-Resolution Genomic Copy Number Variation (CNV) Mapping:

   Frequently employed as a positive control validation standard in clinical genetics labs to calibrate and test the resolution limits of Chromosomal Microarray (CMA), Fluorescence In Situ Hybridization (FISH) probes, and Next-Generation Whole-Genome Sequencing (WGS) workflows.

III Laboratory Thawing, Cultivation, and Passaging Protocols

1. Basal Media Optimization and Environmental Parameters

• Basal Medium Base: Standard Eagle's Minimum Essential Medium (EMEM) with Earle's salts or high-quality Dulbecco's Modified Eagle Medium (DMEM) supplemented with 2 mM L-glutamine.

• Complete Growth Matrix Formulation:

  • EMEM or DMEM basal template

  • Supplemented with 15% premium Fetal Bovine Serum (FBS) (Note: Do not heat-inactivate the serum; primary-like fibroblasts require active growth factors).

  • Fortified with 1% standard Penicillin-Streptomycin dual antibiotic cocktail.

• Environmental Constants (Critical Physiological Tuning):

  • Temperature: 37 °C.

  • Atmospheric Carbon Dioxide ($CO_2$): 5%.

  • Atmospheric Oxygen ($O_2$): 3% (Hypoxic/Physiological Normoxia Environment).

  • Critical Cultivation Note: Primary, untransformed fibroblasts like BioVector® GM04126 are highly sensitive to oxidative stress. Culturing them under standard ambient oxygen (~21% $O_2$) accelerates cellular senescence and stops growth. Utilizing a tri-gas incubator adjusted to 3% $O_2$ significantly enhances proliferation and preserves lifespan.

2. Cryovial Thawing and Recovery Protocol

1. Pre-warm 5 mL of complete expansion medium (15% FBS) in a sterile T25 culture flask to 37 °C.

2. Retrieve the BioVector® GM04126 cryovial from liquid nitrogen and submerge it instantly within a 37 °C water bath. Agitate continuously to melt the contents within 60 seconds.

3. Spray the exterior with 75% ethanol before transfer into the sterile biosafety hood.

4. Transfer the cell suspension slowly into a 15 mL conical tube containing 4 mL of pre-warmed complete growth medium to dilute the toxic DMSO footprint.

5. Centrifuge at 1000 rpm (~200 g) for 5 minutes.

6. Aspirate the supernatant completely, and gently resuspend the cell pellet in 1 - 2 mL of fresh complete expansion medium.

7. Seed the cells into the prepared T25 flask, shake gently in a cross pattern, and incubate under hypoxic parameters (3% $O_2$, 5% $CO_2$). Perform a complete medium change after 24 hours to remove residual unattached cells and debris.

3. Routine Adherent Passaging Workflow (Handling Slow Growth Kinetics)

• Growth Profile & Confluency Control: BioVector® GM04126 grows very slowly. It exhibits pronounced contact inhibition. Passaging must be initialized when the adherent spindle-shaped monolayer achieves 80% confluency. Do not allow cultures to become over-confluent ($\gt 85\%$); dense cultures trigger permanent exit from the cell cycle (senescence), rendering the primary line unculturable.

• Passaging Execution Steps:

  1. Aspirate the spent growth fluid and wash the monolayer once with sterile, calcium/magnesium-free PBS.

  2. Apply a thin layer of 0.25% Trypsin - 0.02% EDTA solution (typically 1 mL for a T25 format) and incubate at 37 °C.

  3. Microscopic Tracking: Monitor continuously under an inverted microscope. Due to primary matrix secretion, trypsinization typically requires 3 – 5 minutes. As soon as cells round up and loosen upon gentle tapping, add 2 volumes of serum-fortified complete medium to deactivate the trypsin.

  4. Pipette gently against the flask wall to dissociate clusters into a single-cell suspension. Avoid vigorous pipetting to prevent mechanical shear damage.

  5. Centrifuge at 1000 rpm for 5 minutes, discard the supernatant, and resuspend the pellet in fresh complete medium.

  6. Split the culture using a conservative standard ratio of 1:2 to 1:3 maximum. Seed into new flasks, top off with complete medium, and return to the incubator.

4. Lifespan and Phenotypic Drift Management

As an untransformed, primary human cell culture, BioVector® GM04126 possesses a finite proliferative capacity (the Hayflick limit).

1. Population Doubling Level (PDL): The cells are typically frozen at low passages (e.g., Passage 14, around 6 PDL).

2. Senescence Tracking: Monitor cell morphology regularly. If the cells lose their narrow spindle-like shape and become excessively large, flattened, and highly granular, they have entered replicative senescence. Discard the batch and re-thaw a fresh vial. Do not use senescent cultures for gene expression profiling or reprogramming experiments.

5. Long-Term Cryopreservation Parameters

• Cryoprotectant Freezing Formula: 80% basal EMEM/DMEM medium + 10% premium Fetal Bovine Serum (FBS) + 10% analytical-grade Dimethyl Sulfoxide (DMSO).

• Controlled-Rate Freezing Protocol:

  1. Harvest highly viable, mid-log phase cultures (approximately 75%-80% confluent). Centrifuge and isolate the pellet.

  2. Resuspend the cells in the pre-chilled cryoprotectant matrix, adjusting the target density to approximately $1.0 \times 10^6$ viable cells per milliliter.

  3. Transfer into sterile cryovials, secure the caps, and place immediately into a standard controlled-rate cooling container (e.g., Mr. Frosty).

  4. Place the container inside a -80 °C ultra-low freezer overnight to achieve a steady cooling rate of -1 °C/minute.

  5. Within 24 hours, transfer the cryovials into liquid nitrogen storage tanks (-196 °C) for long-term preservation. Do not store vials long-term at -80 °C to prevent rapid cell death upon recovery.

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

电话:400-800-2947

工作QQ/微信同号:1843439339

网址http://www.biovector.net